Metropolis Health Peer Comparison
NSE: METROPOLIS | BSE: 542650
₹576.90
₹8.15
(1.43%)
As on 08-Nov-2026IST
Market cap
₹11,974 Cr
Revenue (TTM)
₹1,778 Cr
P/E Ratio
53.4
P/B Ratio
7.3
Div. Yield
0.9 %
Edit
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
11,974 | 37,500 | 33,768 | 30,996 | 15,055 |
Revenue (₹ Cr) |
1,778 | 5,053 | 3,034 | 4,596 | 911 |
Net Profit (₹ Cr) |
225.41 | 613.08 | 588.10 | 193.80 | 203.68 |
Net Margin (%) |
12.46 | 11.89 | 18.68 | 4.17 | 21.86 |
RoE (%) |
14.63 | 15.63 | 23.05 | 6.86 | 20.22 |
Price to Earnings |
53.39 | 60.64 | 57.87 | 145.93 | 73.91 |
Price-To-Book |
7.29 | 8.67 | 12.30 | 7.88 | 14.24 |
Income Statement (₹ Cr)
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,777.63 | 5,053.19 | 3,034.10 | 4,596.20 | 910.96 |
|
Total Income
|
1,808.40 | 5,157.49 | 3,148.70 | 4,646.10 | 931.94 |
|
Total Expenditure
|
1,329.55 | 3,935.28 | 2,140.30 | 3,707.10 | 518.10 |
|
EBITDA
|
448.08 | 1,117.91 | 893.80 | 889.10 | 392.86 |
|
Depreciation
|
135.92 | 267.48 | 178.00 | 385.20 | 100.69 |
|
EBIT
|
312.16 | 850.43 | 715.80 | 503.90 | 292.17 |
|
Interest
|
26.83 | 102.98 | 26.60 | 273.80 | 40.30 |
|
Other Income
|
30.77 | 104.30 | 114.60 | 49.90 | 20.98 |
|
Exceptional Items
|
-8.99 | -36.60 | -30.10 | 2.30 | 0.00 |
|
Profit before Tax
|
307.11 | 815.15 | 773.70 | 282.30 | 272.85 |
|
Provision for Tax
|
81.70 | 202.07 | 185.60 | 88.50 | 69.17 |
|
Profit after Tax
|
225.41 | 613.08 | 588.10 | 193.80 | 203.68 |
Liabilities (₹ Cr)
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,641.54 | 4,323.39 | 2,744.50 | 3,931.80 | 1,057.33 |
|
Minority Interest
|
-1.12 | 5.33 | -4.50 | 15.40 | 0.00 |
|
Non-Current Liabilities
|
316.09 | 1,495.04 | 190.40 | 3,247.20 | 515.16 |
|
Current Liabilities
|
371.40 | 768.03 | 487.70 | 1,412.60 | 160.86 |
|
Total Liabilities
|
2,524.76 | 5,905.00 | 3,139.97 | 7,690.70 | 1,507.05 |
Assets (₹ Cr)
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,414.47 | 3,286.77 | 1,196.40 | 6,040.80 | 773.26 |
|
Current Assets
|
636.38 | 2,088.60 | 1,883.10 | 1,476.90 | 449.80 |
|
Total Assets
|
2,524.76 | 5,905.00 | 3,139.97 | 7,690.70 | 1,507.05 |
|
Total Debt*
|
18.73 | 631.08 | 0.00 | 3,244.00 | 0.00 |
|
Net Current Assets
|
264.99 | 1,320.56 | 1,395.40 | 64.30 | 288.94 |
|
Contingent Liabilities
|
10.08 | 100.01 | 16.76 | 81.10 | 0.13 |
Cashflow (₹ Cr)
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
350.70 | 714.39 | 635.61 | 510.80 | 270.59 |
|
Cash Flow from Investing Activities
|
-223.13 | -1,089.11 | -421.86 | -1,451.70 | -174.22 |
|
Cash from Financing Activities
|
-115.29 | 271.85 | -263.57 | 940.30 | -69.49 |
|
Net Cash Inflow / Outflow
|
12.28 | -102.87 | -49.83 | -0.60 | 26.88 |
Ratios
Profitability Ratios
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
ROCE (%)
|
20.03 | 19.38 | 29.56 | 11.51 | 30.28 |
|
ROE (%)
|
14.63 | 15.63 | 23.05 | 6.86 | 20.22 |
|
ROA (%)
|
10.40 | 10.20 | 18.33 | 2.49 | 13.04 |
|
EBIT Margin (%)
|
17.56 | 16.83 | 23.59 | 10.96 | 32.07 |
|
Net Margin (%)
|
12.46 | 11.89 | 18.68 | 4.17 | 21.86 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
19.84 | 26.18 | 16.71 | 35.12 | 24.47 |
|
EBIT Growth (%)
|
46.75 | 16.83 | 20.83 | -10.81 | 38.42 |
|
Net Profit Growth (%)
|
41.91 | 9.16 | 8.95 | -45.50 | 33.97 |
|
EPS Growth (%)
|
-40.95 | 13.12 | -43.47 | -36.93 | 33.02 |
|
Book Value Growth (%)
|
13.54 | 16.51 | 15.41 | 5.13 | 21.86 |
Valuation Ratios
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Price / Earnings
|
31.93 | 57.91 | 55.72 | 142.76 | 73.84 |
|
Price / Book Value
|
7.29 | 8.67 | 12.30 | 7.88 | 14.24 |
|
Dividend Yield (%)
|
0.87 | 0.04 | 1.02 | 0.00 | 0.14 |
|
EV/EBITDA
|
26.31 | 33.10 | 36.29 | 38.41 | 37.61 |
|
Market Cap (₹ Cr)
|
8,992.90 | 25,841.07 | 22,015.15 | 24,901.98 | 8,864.05 |
Solvency Ratios
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 0.00 | 0.49 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | -- | -- | 0.15 | -- |
|
Current Ratio
|
1.71 | 2.72 | 3.86 | 1.05 | 2.80 |
|
Quick Ratio
|
1.58 | 2.60 | 3.75 | 0.96 | 2.74 |
|
Interest Coverage
|
12.45 | 8.92 | 30.09 | 2.03 | 7.77 |
Operating Efficiency Ratios
| Metropolis Health | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
10.36 | 10.34 | 4.66 | 15.03 | 1.97 |
|
Asset Turnover
|
0.82 | 0.84 | 0.95 | 0.59 | 0.58 |
|
Receivable days
|
35.29 | 29.09 | 13.13 | 44.38 | 7.98 |
|
Inventory Days
|
10.35 | 6.05 | 5.28 | 7.52 | 2.20 |
|
Payable days
|
143.56 | 80.04 | 118.67 | 133.54 | 136.27 |
|
Cash Conversion Cycle
|
-97.92 | -44.90 | -100.26 | -81.64 | -126.08 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
